Published online Jun 15, 2001. doi: 10.3748/wjg.v7.i3.403
Revised: June 13, 2000
Accepted: June 29, 2000
Published online: June 15, 2001
- Citation: Xu AG, Li SG, Liu JH, Gan AH. Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. World J Gastroenterol 2001; 7(3): 403-406
- URL: https://www.wjgnet.com/1007-9327/full/v7/i3/403.htm
- DOI: https://dx.doi.org/10.3748/wjg.v7.i3.403
In China, the incidence and mortality of gastric cancer rank the second among all cancers. Recent studies indicate apoptosis could play a role in the development of cancer[1-20]. The aim of this study was investigat the insight of apoptosis and bcl-2, p53 and C-myc protein expression in the development of gastric cancer.
All 122 specimens were collected by gastroscopy or surgical resection. Among these, 32 were chronic active gastritis, 29 were gastric ulcer, 17 were mild non-classic proliferation, 8 were severe non-classic proliferation, 6 were early gastric cancer, and 30 were progressive gastric cancer. The average age among those types of samples were 49.2, 46.3, 45.8, 50.3, 49.3 and 51.0, while the ratio of men to women was 20/12, 21/8, 11/6, 5/3, 5/1 and 21/9, respectively. There was no significant regularity among those samples after analyzed by statistics.
Apoptosis was detected using the TUNEL technique as reported by Ishida[1]. Cells in which the nuclear or cytoplasm was dyed brown were identified to be undergoing apoptosis. We observed five visual fields for each spechmen, and 100 nuclei were observed in each visual field. The average ratio of apoptosis cell was apoptosis index. Proteins bcl-2, p53, and C-myc were dyed by the ABC immunohistochemical method. Cells with obvious brown or deep brown after dying were defined to be positive.
The apoptosis index increased stepwise from chronic active gastritis to gastric ulcer and decreased from non-classic proliferation to early gastric cancer and progressive gastric cancer (Table 1). The expression of protein bcl-2 and C-myc increased progressively as follows: chronic active gastritis, gastric ulcer, mild non-classic proliferation, severe non-classic proliferation, and early gastric cancer. The expression of protein bcl-2 decreased when it developed into progressive gastric cancer while that of C-myc increased continually. Protein p53 was expressed only in severe non-classic proliferation gastric mucosa and gastric cancer.
Chronic active gastritis | Gastric ulcer | Non-classic proliferation | Gastric cancer | |||
Mild | Severe | Early | Progressive | |||
Sample numbers | 32 | 29 | 17 | 8 | 6 | 30 |
Apoptosis index% | 16.8 ± 12.3 | 24.1 ± 20.0a | 19.3 ± 16.4 | 15.7 ± 15.2c | 10.1 ± 9.1d | 6.3 ± 6.0e |
Bcl-2 positive | 3 | 8 | 9 | 6 | 5 | 14 |
Numbers(%) | (9.4) | (27.6)a | (52.9)b | (75.0)c | (83.3) | (46.7)e |
C-myc positive | 5 | 6 | 6 | 4 | 3 | 20 |
Numbers(%) | (15.6) | (20.7) | (35.3)b | (50.0) | (50.0) | (63.3)e |
p53 positive | 0 | 0 | 0 | 2 | 2 | 19 |
Numbers(%) | (25.0)c | (33.3) | (63.3)e |
The apoptosis index, C-myc and p53 expression of intestinal type were higher than that of diffuse type (P < 0.05), while the bcl-2 expression was lower (P < 0.05). The two types had the opposite outcomes (Table 2).
Apoptosis, programmed cell death, was first described by Kerr et al[21]. It is the programmed death of cells by fragmentation of DNA, cell shrinkage, and dilation of endoplasmic reticulum, followed by cell fragmentation and formation of membrane vesicles called apoptosis bodies[21-24]. Recent investigations have demonstrated that apoptosis plays a significiant role in the pathogenesis of tumors[25-30]. Screnhst have began to have realize that apoptosis, in concert with cell proliferation, is an important mechanism towards healthy tissues. Abnormal apoptosis contirbutes to the onset, development, and progression of cancer[2,31]. Stomach carcinoma is estimated to be one of the most frequent cancers worldwide[32-34].
According to Lauren, stomach cancer can be divided into adenocarcinomas of diffuse and intestinal types[35]. Ishida et al[1] reported the presence of apoptosis in gastric cancer tissue by using terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. They pointed out that apoptosis played a decisive function in pre-cancer changes and participated in the development of cancer, including epithelial hyperplasia which occurrs in the gastric mucosa. The apoptosis action in sick gastric mucosa cells decreased, cell life was prolonged, and cells were piled up. This may be the reason why gastric cancer developes, infiltrates and transfers. Kasagi et al[10] studied the apoptosis indexes of various levels of differentiation. There was some difference between tumor tissue of high and low differentiations (apoptosis indexes were 10.9% and 4.0%, respectively, P < 0.01). The difference indicated gastric cancer which had a low differentiation was less likely to undergo apoptosis. Non-classic proliferation of gastric mucosa was considered to be a precancerous change. Mijic et al[36] reported that numeric densities of apoptosis cell are associated with tumor progression in human gastric carcinogenesis. We found that the apoptosis index decreased from mild non-proliferation to severe non-proliferation, early gastric cancer, and progressive gastric cancer. This indicated that during the development of gastric cancer, apoptosis was inhibited.
The mechanism of apoptosis modulation of gastric-intestinal epithelia is very complicated. Many genes and factors are involved. Various proteins or oncogenes and suppressor gene are involved in the process of apoptosis, including p53, bcl-2, myc, ras, Bax and the Fas/Fas system[37-41]. Bax protein expression has been identified in various human malignant tissues[7,15,42,43]. Research has indicated that bcl-2 is an inhibitor of apoptosis. Li et al[44] reported that abnormal c-myc and bcl-2 expression is an important factor in biological behavior of gastric carcinoma and can regulate apoptosis. Sundblad et al[8] found that the expression of bcl-2 increased in cells of gastric cancer. Bcl-2 appears to not only inhibit apoptosis, but the protein be an antagonist of apoptosis mediated by oncogenesis suppressor genes. When the expression of bcl-2 increased, cancer cells would resist the apoptosis induced by chemical drugs or γ-radiation during therapy. Our results indicates that when non-classic proliferation occurrs in gastric mucosa, the expression of bcl-2 increases significantly. Expression of bcl-2 reached the top at the early stage of gastric cancer and decreased in the progressive gastric cancer. bcl-2 might do some work both in the triggering of gastric cancer and developing of early gastric cancer. Although bcl-2 was a strong inhibitor to apoptosis, it could not induce the cancer alone. However, cancer has been associated with bcl-2 in combination with C-myc[45].
Gastric carcinogenesis is a gradually developed process which result from the sequential alteration of multigenes[1,46-48]. Gene p53 is an oncogenetic repressor. Its anti-cancer function has been realized by triggering apoptosis. If gene p53 is inhibited, apoptosis can not be induced. Ikeda et al[49] observed that the progression of gastric cancer is defined by a gradual increase of proliferation activity and constant occurrence of apoptosis. Furthermore, Ikeda reported that the naturally occurring apoptosis is induced predominantly via a p53-gene-independent pathway. The half life of the mutant protein p53 is prolonged when gene p53 is mutated. It is easy to detect by immunohistochemical methods. We observed that expression of p53 was mainly in progressive gastric cancer tissue. No p53 was observed in the tissue of benign stomach diseases and mild non-classic proliferation. This indicated that the mutation of p53 might be an event in the late gastric cancer. The cooperation of bcl-2 and C-myc could inhibit the biological function of p53 to suppress cell growth by keeping it in the cytoplasm. Meanwhile, the co-expression of p53 and C-myc would lead to cell apoptosis and inhibit oncogenesis[50,51]. The co-expression of bcl-2 and C-myc in the same carcinoma tissue indicates a higher level of malignancy and a lack of sensitivity to chemical therapy and radiotherapy. The prognosis is not favorable. On the other hand, the co-expression of C-myc and p53 indicates a low level of malignancy, less sensitivity to chemical therapy and radiotherapy, and a favorable prognosis. Therefore p53 status and the expression of bcl-2 by tumor cells might be good indicators of sensitivity to chemotherapy for patients with gastric cancer[52].
Different pathological types of gastric cancer are associated with different physiological mechanisms. Intestinal gastric cancer had a higher level of differentiation and a closer relationship with gastric epithelial metaplasia as compared with diffuse type of gastric cancer. We observed intestinal type cancer more frequently among men and among older patients. Intestinal type cancer had a more favorable prognosis than diffuse type cancer. Also, the index of intestinal type of gastric cancer was higher than that of diffuse type (P < 0.05), with lower expression of bcl-2 and higher expression of C-myc and p53. These results indicate that the pathogenic mechanism might be different between those two types of gastric cancer. Vollmers et al[53] had similar results, reporting that the gene expression modulation of apoptosis and the apoptosis indexes were different between type intestinal and diffuse gastric cancer. The apoptosis mechanism was different between those two types of gastric cancer.
Dr. An-Gao Xu, graduated from Guangdong Medical College in 1984. He is an associate physician-in-chief, specializing in the research and treatment of gastrointestinal and liver tumors. He has published 24 papers and 1 book.
Edited by Jason Carr
1. | Ishida M, Gomyo Y, Tatebe S, Ohfuji S, Ito H. Apoptosis in human gastric mucosa, chronic gastritis, dysplasia and carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling. Virchows Arch. 1996;428:229-235. [PubMed] [Cited in This Article: ] |
2. | Martin SJ, Green DR. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol. 1995;18:137-153. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 113] [Cited by in F6Publishing: 121] [Article Influence: 4.2] [Reference Citation Analysis (0)] |
3. | Guo YQ, Zhu ZH, Li JF. Flow cytometric analysis of apoptosis and proliferation in gastric cancer and precancerous lesion. Shijie Huaren Xiaohua Zazhi. 2000;8:983-987. [Cited in This Article: ] |
4. | Li J, Wang WL, Liu B. Angiogenesis and apoptosis in human hepatocellular carcinoma. Huaren Xiaohua Zazhi. 1998;6:1057-1060. [Cited in This Article: ] |
5. | Peng XM, Peng WW, Chen Q, Yao JL. Apoptosis, Bcl-2 and p53 protein expressions in tissues from hepatocellular carcinoma. Huaren Xiaohua Zazhi. 1998;6:834-836. [Cited in This Article: ] |
6. | Chen RF, Zou SQ, Qian JQ. Apoptosis and expression of bcl-2 gene in gallbladder neoplasms. Huaren Xiaohua Zazhi. 1998;6:680-682. [Cited in This Article: ] |
7. | Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S, Reed JC. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 1995;55:4471-4478. [PubMed] [Cited in This Article: ] |
8. | Sundblad AS, Tamayo R. [Expression of MIB-1/KI-67 and bcl-2 in gastric carcinoma. Relationship with clinico-pathological factors]. Acta Gastroenterol Latinoam. 1995;25:67-72. [PubMed] [Cited in This Article: ] |
9. | Lu SY, Pan XZ, Peng XW, Shi ZL, Lin L, Chen MH. Effect of Hp infection on gastric epithelial cell kinetics in stomach diseases. Shijie Huaren Xiaohua Zazhi. 2000;8:386-388. [Cited in This Article: ] |
10. | Kasagi N, Gomyo Y, Shirai H, Tsujitani S, Ito H. Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Jpn J Cancer Res. 1994;85:939-945. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 2.4] [Reference Citation Analysis (0)] |
11. | Liang WJ, Huang ZY, Ding YQ, Zhang WD. Lovo cell line apoptosis induced by cycloheximide combined with TNFα. Shijie Huaren Xiaohua Zazhi. 1999;7:326-328. [Cited in This Article: ] |
12. | Shi JS, Hao XY. Oncogene, antioncogene, apoptosis and primary gallbladder carcinoma. Huaren Xiaohua Zazhi. 1998;6:430-431. [Cited in This Article: ] |
13. | Shen YF, Zhuang H, Shen JW, Chen SB. Cell apoptosis and neoplasms. Shijie Huaren Xiaohua Zazhi. 1999;7:267-268. [Cited in This Article: ] |
14. | Yuan RW, Ding Q, Jiang HY, Qin XF, Zou SQ, Xia SS. Bcl-2, p53 protein expression and apoptosis in pancreatic cancer. Shijie Huaren Xiaohua Zazhi. 1999;7:851-854. [Cited in This Article: ] |
15. | Chresta CM, Masters JR, Hickman JA. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax: Bcl-2 ratio. Cancer Res. 1996;56:1834-1841. [PubMed] [Cited in This Article: ] |
16. | Chen CJ, Sun YX, Zhou HG, Pan BR, Zheng SG, Hong XZ, Liu JH, Feng WY. Bcl-2 and p53 expressions in colorectal adenoma and carcinoma. Huaren Xiaohua Zazhi. 1998;6:683-685. [Cited in This Article: ] |
17. | Wang JY. Current status of studies on relationship between Hp infection and stomach cancer. Huaren Xiaohua Zazhi. 1998;6:829-830. [Cited in This Article: ] |
18. | Li J, Wang WL, Wang WY, Liu B, Wang BY. Apoptosis in human hepatocellular carcinoma by terminal deoxynucleotidyl transferase-mediate dUTP-FITC nick end labeling. Huaren Xiaohua Zazhi. 1998;6:491-494. [Cited in This Article: ] |
19. | Xu A, Li S, Liu J. [Correlation between apoptosis and proliferation in gastric pre-carcinoam]. Zhonghua Yixue Zazhi. 1999;79:185-186. [PubMed] [Cited in This Article: ] |
20. | Qiao Q, Wu JS, Zhang J, Ma QJ, Lai DN. Expression and significance of apoptosis related gene bcl-2, bax in human large intestine adenocarcinoma. Shijie Huaren Xiaohua Zazhi. 1999;7:936-938. [Cited in This Article: ] |
21. | Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 9960] [Cited by in F6Publishing: 9765] [Article Influence: 187.8] [Reference Citation Analysis (0)] |
22. | Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-306. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 4980] [Cited by in F6Publishing: 4825] [Article Influence: 109.7] [Reference Citation Analysis (0)] |
23. | Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980;284:555-556. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3159] [Cited by in F6Publishing: 3091] [Article Influence: 70.3] [Reference Citation Analysis (0)] |
24. | Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 1984;142:67-77. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1083] [Cited by in F6Publishing: 1051] [Article Influence: 26.3] [Reference Citation Analysis (0)] |
25. | Que FG, Gores GJ. Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology. 1996;110:1238-1243. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 142] [Cited by in F6Publishing: 147] [Article Influence: 5.3] [Reference Citation Analysis (0)] |
26. | Liu HF, Liu WW, Fang DC, Men RP. Relationship between Fas antigen expression and apoptosis in human gastric carcinoma and adjacent noncancerous tissues. Huaren Xiaohua Zazhi. 1998;6:321-322. [Cited in This Article: ] |
27. | Liu HF, Liu WW, Fang DC. Study of the relationship between apoptosis and proliferation in gastric carcinoma and its precancerous lesion. Shijie Huaren Xiaohua Zazhi. 1999;7:649-651. [Cited in This Article: ] |
28. | Xu AG, Li SG, Liu JH, Gan AH. Significance of apoptosis and expression of bcl-2 in gastric pre-carcinoma and cancer. Guangdong Yixue. 1998;19:489-490. [Cited in This Article: ] |
29. | Gan AH, Xu AG, Liu JH. The apoptosis and expression of c-myc in gastric cancer. Chin J Intern Med. 1999;38:783. [Cited in This Article: ] |
30. | Solary E, Dubrez L, Eymin B. The role of apoptosis in the pathogenesis and treatment of diseases. Eur Respir J. 1996;9:1293-1305. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
31. | Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell. 1991;65:1097-1098. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 597] [Cited by in F6Publishing: 646] [Article Influence: 19.6] [Reference Citation Analysis (0)] |
32. | Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554-3560. [PubMed] [Cited in This Article: ] |
33. | Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-6740. [PubMed] [Cited in This Article: ] |
34. | Correa P. Clinical implications of recent developments in gastric cancer pathology and epidemiology. Semin Oncol. 1985;12:2-10. [PubMed] [Cited in This Article: ] |
35. | LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31-49. [PubMed] [Cited in This Article: ] |
36. | Mijic A, Ferencic Z, Belicza M, Fucic A, Sevic SR, Sarcevic B, Bekavac-Beslin M, Grbesa M, Golubic D, Horzic M. Apoptosis in human gastric polyps and adenocarcinomas: a stereological analysis. Hepatogastroenterology. 1998;45:684-690. [PubMed] [Cited in This Article: ] |
37. | Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, Williams GT. Apoptosis: molecular regulation of cell death. Eur J Biochem. 1996;236:1-26. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 436] [Cited by in F6Publishing: 460] [Article Influence: 16.4] [Reference Citation Analysis (0)] |
38. | Liu HF, Liu WW, Fang DC, Yang SM, Wang RQ. Bax gene expression and its relationship with apoptosis in human gastric carcinoma and precancerous lesions. Shijie Huaren Xiaohua Zazhi. 2000;8:665-668. [Cited in This Article: ] |
39. | Xue XC, Fang GE, Hua JD. Gastric cancer and apoptosis. Shijie Huaren Xiaohua Zazhi. 1999;7:359-361. [Cited in This Article: ] |
40. | Jiang YG, Li QF, Wang YM, Gu CH. Bcl2/Bax expression and hepatocyte apoptosis on liver tissues in tupaia with HDV/HBV infection. Shijie Huaren Xiaohua Zazhi. 2000;8:625-628. [Cited in This Article: ] |
41. | Gu XH, Li QF, Wang YM. Expression of hepatocyte apoptosis and Fas/FasL in liver tissues of patients with hepatitis D. Shijie Huaren Xiaohua Zazhi. 2000;8:35-38. [Cited in This Article: ] |
42. | Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res. 1996;56:2422-2427. [PubMed] [Cited in This Article: ] |
43. | Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S, Reed JC. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol. 1996;148:1567-1576. [PubMed] [Cited in This Article: ] |
44. | Li XL, Hao YR, Zou JX, Yang JH, Geng JH. Relationship between C-myc and Bcl-2 alterations and biological behavior and apoptosis in gastric cancer. Xin Xiaohuabingxue Zazhi. 1997;5:773-774. [Cited in This Article: ] |
45. | Steller H. Mechanisms and genes of cellsuicide. Science. 1995;267:1455. [DOI] [Cited in This Article: ] [Cited by in Crossref: 1812] [Cited by in F6Publishing: 1747] [Article Influence: 60.2] [Reference Citation Analysis (0)] |
46. | Pan CJ, Zhong P, Huang XR, Liu KY, Wang SX. Study on the correlation between proliferation and apoptosis in atrophy and intestinal metaplasia of gastric mucosa. Shijie Huaren Xiaohua Zazhi. 2000;8:143-146. [Cited in This Article: ] |
47. | Xia HX, Zhang GS. Apoptosis and proliferation in gastric cancer caused by Hp infection. Shijie Huaren Xiaohua Zazhi. 1999;7:740-742. [Cited in This Article: ] |
48. | Tu SP, Jiang SH, Tan JH, Jiang XH, Qiao MM, Zhang YP, Wu YL, Wu YX. Proliferation inhibition and apoptosis induction by arsenic trioxide on gastric cancer cell SGC-7901. Shijie Huaren Xiaohua Zazhi. 1999;7:18-21. [Cited in This Article: ] |
49. | Ikeda M, Shomori K, Endo K, Makino T, Matsuura T, Ito H. Frequent occurrence of apoptosis is an early event in the oncogenesis of human gastric carcinoma. Virchows Arch. 1998;432:43-47. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
50. | Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell. 1993;74:777-779. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 620] [Cited by in F6Publishing: 602] [Article Influence: 19.4] [Reference Citation Analysis (0)] |
51. | Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G, Thompson CB. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74:597-608. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2197] [Cited by in F6Publishing: 2241] [Article Influence: 72.3] [Reference Citation Analysis (0)] |
52. | Ikeguchi M, Tatebe S, Kaibara N, Ito H. Changes in levels of expression of p53 and the product of the bcl-2 in lines of gastric cancer cells during cisplatin-induced apoptosis. Eur Surg Res. 1997;29:396-402. [PubMed] [Cited in This Article: ] |
53. | Vollmers HP, Dämmrich J, Hensel F, Ribbert H, Meyer-Bahlburg A, Ufken-Gaul T, von Korff M, Müller-Hermelink HK. Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma. Cancer. 1997;79:433-440. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 2] [Reference Citation Analysis (0)] |